Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.24.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, no par value $ 0 $ 0
Common stock, shares authorized Unlimited Unlimited
Common stock, shares issued 5,841,045 315,916
Common stock, shares outstanding 5,841,045 315,916